Abstract
Malaria is one of the most important infectious diseases in the world. It is estimated that 2.1 billion people live in areas of the world where malaria is transmitted and that there are 100–300 million new cases of malaria and one to two million deaths caused by malaria every year (WHO 1991). In the past 10–20 years, the severity of the malaria problem has worsened in many areas because of the emergence of drug-resistant strains of the parasite, resistance to insecticides of the Anopheles sp. mosquitoes that transmit the disease, socioeconomic problems that have led to a decreased capacity to optimally utilize existing tools to combat the disease, and movement of nonimmune populations into areas where malaria is transmitted. Accordingly, there are now renewed efforts to control this disease. A major focus of research efforts is to develop vaccines against malaria, including vaccines designed to produce protective cytotoxic T lymphocytes (CTL; Hoffman et al. 1991). To understand how such vaccines might work, it is important to understand the life cycle of the parasite.
The opinions and assertions herein are the private ones of the authors and are not to be construed as official or as reflecting the views of the U.S. Navy or the Naval Service at large.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Aggarwal A, Kumar S, Jaffe R, Hone D, Gross M, Sadoff J (1991) Oral Salmonella: malaria circumsporozoite recombinants induce specific CD8+ cytotoxic T cells. J Exp Med 172: 1083–1090
Alonso PL, Lindsay SW, Armstrong JR, Conteh M, Hill AG, David PH, Fegan G (1991) The effect of insecticide-treated bed nets on mortality of Gambian children. Lancet 337: 1499–1502
Campbell JR (1989) DNA sequence of the gene encoding a Plasmodium falciparum malaria candidate vaccine antigen. Nucleic Acids Res 17:5854
Caspers P, Gentz R, Matile H, Pink JR, Sinigaglia F (1989) The circumsporozoite protein gene from NF54, a Plasmodium falciparum isolate used in malaria vaccine trial. Mol Biochem Parasitol 35:185–190
Charoenvit Y, Leef ML, Yuan LF, Sedegah M, Beaudoin RL (1987) Characterization of Plasmodium yoelii monoclonal antibodies directed against stage-specific antigens. Infect Immun 55:604–608
Chen DH, Tigelaar RE, Weinbaum FI (1977) Immunity to sporozoite-induced malaria infection in mice. 1. The effect of immunization of T and B cell-deficient mice. J Immunol 118: 1322–1327
Clyde DF, McCarthy VC, Miller RM, Hornick RB (1973) Specificity of protection of man immunized against sporozoite-induced falciparum malaria. Am J Med Sci 266:398–401
Dame J B, Williams J L, McCutchan TF, Weber JL, Wirtz RA, Hockmeyer WT, Sanders GS, Reddy EP, Maloy WL, Haynes JD, Schneider I, Roberts D, Diggs CL, Miller LH (1984) Structure of the gene encoding the immunodominant surface antigen on the sporozoite of the human malaria parasite Plasmodium falciparum. Science 225:593–599
Del Giudice G, Grillot D, Renia L, Muller I, Corradin G, Louis JA, Mazier D, Lamberd PH (1990) Peptide-primed CD4+ cells and malaria sporozoites. Immunol Lett 25:59–64
Doolan DL, Houghten RA, Good MF (1991) Location of human cytotoxic T cell epitopes within a polymorphic domain of thePlasmodium falciparum circumsporozoite protein. Int Immunol 3:511–506
Doolan DL, Saul AJ, Good MF (1992) Geographically restricted heterogeneity of the Plasmodium falciparum circumsporozoite protein; relevance for vaccine development. Infect Immun 60:675–682
Egan JE, Weber JL, Ballou WR, Hollingdale MR, Majarian WR, Görden DM, Maloy WE, Hoffman SL, Wirtz RA, Schneider I, Woollett GR, Young JF and Hockmeyer WT (1987) Efficacy of murine malaria sporozoite vaccines: implications for human vaccine development. Science 236:453–456
Egan JE, Hoffman SL, Haynes JD, Sadoff JC, Schneider I, Grau GE, Hollingdale MR, Ballou WR, Gordon DM (1993) Humoral immune response in volunteers immunized with irradiated Plasmodium falciparum sporozoites. Am J Trop Med Hyg (in press)
Fairley NH (1947) Sidelights on malaria in man obtained by subinoculation experiments. Trans R Soc Trop Med Hyg 40: 621–676
Flynn JL, Weiss WR, Norris KA, Seifert HS, Kumar S, So M (1990) Generation of a cytotoxic T-lymphocyte response using a Salmonella antigen-delivery system. Mol Microbiol 4: 2111–2118
Good MF, Kumar S, Miller LH (1988) The real difficulties for malaria sporozoite vaccine development: nonresponsiveness and antigenic variation. Immun Today 9:351–355
Guerin-Marchand C, Druilhe P, Galey B, Londono A, Patarapotikul J, Beaudoin RL, Dubeaux C, Tartar A, Mercereau-Puijalon O, Langsley G (1987) A liver-stage-specific antigen of Plasmodium falciparum characterized by gene cloning. Nature 329:164–167
Hedstrom RC, Campbell JR, Leef ML, Charoenvit Y, Carter M, Sedegah M, Beaudoin RL, Hoffman SL (1990) A malaria sporozoite surface antigen distinct from the circumsporozoite protein. Bull WHO 68:152–157
Hill AV, Allsopp CE, Kwiatkowski D, Anstey NM, Twumasi P, Rowe PA, Bennett S, Brewster D, McMichael AJ, Greenweed BM (1991) Common west African HLA antigens are associated with protection from severe malaria. Nature 352: 595–600
Hill AV, Elvin J, Willis AC, Aidoo M, Allsopp CE, Gotch FM, Gao XM, Takiguchi M, Greenwood BM, Townsand AR, McMichael AJ, and Whittle HC (1992) Molecular analysis of the association of HLA-B53 and resistance to severe malaria. Nature 360:434–439
Hoffman SL, Isenbarger D, Long GW, Sedegah M, Szarfman A, Waters L, Hollingdale MR, van der Miede PH, Finbloom DS, Ballou WR (1989a) Sporozoite vaccine induces genetically restricted T cell elimination of malaria from hepatocytes. Science 244:1078–1081
Hoffman SL, Oster CN, Mason C, Beier JC, Sherwood JA, Ballou WR, Mugambi M, Chulay JD (1989b) Human lymphocyte proliferative response to a sporozoite T cell epitope correlates with resistance to falciparum malaria. J Immunol 142:1299–1303
Hoffman SL, Nussenzweig V, Sadoff JC, Nussenzweig RS (1991) Progress toward malaria preerythrocytic vaccines. Science 252: 520–521
Khusmith S, Charoenvit Y, Kumar S, Sedegah M, Beaudoin RL, Hoffman SL (1991) Protection against malaria by vaccination with sporozoite surface protein 2 plus CS protein. Science 252:715–718
Kumar S, Miller LH, Quakyi IA, Keister DB, Houghten RA, Maloy WL, Moss B, Berzofsky JA, Good MF (1988) Cytotoxic T cells specific for the circumsporozoite protein of Plasmodium falciparum. Nature 334:258–260
Lockyer MJ, Marsh K, Newbold CI (1989) Wild isolates of Plasmodium falciparum show extensive polymorphism in T cell epitopes of the circumsporozoite protein. Mol Biochem Parasitol 37:275–280
Malik A, Egan JE, Houghton RA, Sadoff JC, Hoffman SL (1991) Human cytotoxic T lymphocytes against Plasmodium falciparum circumsporozoite protein. Proc Natl Acad Sei USA 88:3300–3304
Meis JFGM, Jap PHK, Verhave JP, Meuwissen JHET (1987) Cellular response against exoerythrocytic forms ofPlasmodium berghei in rats. Am J Trop Med Hyg 30:506–510
Moelans HMD, Meiss JFGM, Kocken C, Konongs RNH, Schoemakers JGG (1991) A novel protein antigen of the malaria parasite Plasmodium falciparum, located on the surface of gametes and sporozoites. Mol Biochem Parasitol 45:193–204
Moreno A, Clavijo P, Edelman R, Davis J, Sztein M, Herrington D, Nardin E (1991) Cytotoxic CD4+ T cells from a sporozoite-immunized volunteer recognize thePlasmodium falciparum CS protein. Int Immunol 3:997–1003
Nussenzweig R, Vanderberg J, Most H (1969) Protective immunity produced by the injection of x-irradiated sporozoites of Plasmodium berghei: IV. Dose response, specificity and humoral immunity. Milit Med 134:1176–1182
Renia L, Marussig MS, Grillot D, Pied S, Corradin G, Miltgen F, Del Giudice G, Mazier D (1991) In vitro activity of CD4+ and CD8+ T lymphocytes from mice immunized with a synthetic malaria peptide. Proc Natl Acad Sei USA 88:7963–7967
Rieckmann KH, Beaudoin RL, Cassells JS, Sell DW (1979) Use of attenuated sporozoites in the immunization of human volunteers against falciparum malaria. Bull WHO 57:261–265
Robson KJH, Hall J RS, Jennings MW, Harris TJR, Marsh K, Newbold CI, Tate VE, Weatherall DJ (1988) A highly conserved amino-acid sequence in thrombospondin, properdin and in proteins from sporozoites and blood stages of a human malaria parasite. Nature 335:79–82
Rodrigues MM, Cordey A-S, Arreaza G, Corradin G, Romero P, Maryanski JL, Nussenzweig RS, Zavala F (1991) CD8+ cytolytic T cell clones derived against the Plasmodium yoelii circumsporozoite protein protect against malaria. Int Immunol 3: 579–586
Rodrigues MM, Nussenzweig RS, Romero P, Zavala F (1992) The in vivo cytotoxic activity of CD8+ T cell clones correlates with their levels of expression of adhesion molecules. J Exp Med 175:895–905
Rogers WO, Malik A, Mellouk S, Nakamura K, Rogers MD, Szarfman A, Gordon DM, Nussler AK, Aikawa M, Hoffman SL (1992a) Characterization of Plasmodium falciparum sporozoite surface protein 2. Proc Natl Acad Sci USA 89:9176–9180
Rogers WO, Rogers MD, Hedstrom RC, Hoffman SL (1992b) Characterization of the gene encoding sporozoite surface protein 2, a protective Plasmodium yoelii sporozoite antigen. Mol Biochem Parasitol 53:45–52
Romero P, Maryanski JL, Corradin G, Nussenzweig RS, Nussenzweig V, Zavala F (1989) Cloned cytotoxic T cells recognize an epitope in the circumsporozoite protein and protect against malaria. Nature 341:323–325
Satchidanandam V, Zavala F, Moss B (1991) Studies using a recombinant vaccinia virus expressing the circumsporozoite protein of Plasmodium berghei. Mol Biochem Parasitol 48: 89–100
Schofield L, Villaquiran J, Ferreira A, Schellekens H, Nussenzweig RS, Nussenzweig V (1987) Gamma-interferon, CD8+ T cells and antibodies required for immunity to malaria sporozoites. Nature 330:664–666
Sedegah M, Chiang CH, Weiss WR, Mellouk S, Cochran MD, Houghton RA, Beaudoin RL, Smith D, Hoffman SL (1992a) Recombinant Pseudorabies virus carrying a Plasmodium gene: herpesvirus as a new live viral vector for inducing T- and B-cell immunity. Vaccine 10: 578–584
Sedegah M, Sim BKL, Mason C, Nutman T, Malik A, Roberts C, Johnson A, Ochola J, Koech D, Were B, Hoffman SL (1992b) Naturally acquired CD8+ cytotoxic T lymphocytes against Plasmodium falciparum circumsporozoite protein. J Immunol 149:966–971
Shi Y-P, Alpers MP, Povoa MM, Lai AA (1992) Diversity in the immunodominant determinants of the circumsporozoite protein ofPlasmodium falciparum parasites from malaria-endemic regions of Papua New Guinea and Brazil. Am J Trop Med Hyg 47:844–851
Sinigaglia F, Guttinger M, Kilgus J, Doron DM, Matile H, Etlinger H, Trezeciak A, Gillessen D and Pink JRL (1988) A malaria T cell epitope recognized in association with most mouse and human MHC class II molecule. Nature 336: 778–780
Tsuji M, Romero P, Nussenzweig RS, Zavala F (1990) CD4+ cytolytic clone confers protection against murine malaria. J. Exp Med 172:1353–1357
Vanderberg J, Nussenzweig R, Most H (1969) Protective immunity produced by the injection of X-irradiated sporozoites of Plasmodium berghei. V. In vitro effects of immune serum on sporozoites. Milit Med 134:1183–1190
Verhave JP, Strickland GT, Jaffe HA, Ahmed A (1978) Studies on the transfer of protective immunity with lymphoid cells from mice immune to malaria sporozoites. Immunol 121: 1031–1033
Weiss WR, Sedegah M, Beaudoin RL, Miller LH, Good MF (1988) CD8+ T cells (cytotoxic/suppressors) are required for protection in mice immunized with malaria sporozoites. Proc Natl Acad Sci USA 85:573–576
Weiss WR, Mellouk S, Houghten RA, Sedegah M, Kumar S, Good MF, Berzofsky JA, Miller LH, Hoffman SL (1990) Cytotoxic T cells recognize a peptide from the circumsporozoite protein on malaria-infected hepatocytes. J Exp Med 171:763–773
Weiss WR, Berzovsky JA, Houghten R, Sedegah M, Hollingdale M, Hoffman SL (1992) A T cell clone directed at the circumsporozoite protein which protects mice against bothP. yoelii and P. berghei. J Immunol (in press)
WHO (1991) World Health Organization Expert Committee on Biological Standardization. Techn Rep Ser 610:1977
Yano A, Aosai F, Ohta M, Hasekura H, Sugane K, Hayashi S (1989) Antigen presentation by Toxoplasma gondii-infected cells to CD4+ proliferative T cells and CD8+ cytotoxic cells. J Parasitol 75:411–416
Yoshida N, Nussenzweig RS, Ptocynjak P, Nussenzweig V, Aikawa M (1980) Hybridoma produces protective antibodies directed against the sporozoite stage of malaria parasites. Science 207:71–73
Zhu J, Hollingdale MR (1991) Structure of Plasmodium falciparum liver stage antigen-1. Mol Biochem Parasitol 48:223–226
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1994 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Hoffman, S.L., Sedegah, M., Malik, A. (1994). Cytotoxic T Lymphocytes in Humans Exposed to Plasmodium falciparum by Immunization or Natural Exposure. In: Oldstone, M.B.A. (eds) Cytotoxic T-Lymphocytes in Human Viral and Malaria Infections. Current Topics in Microbiology and Immunology, vol 189. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-78530-6_11
Download citation
DOI: https://doi.org/10.1007/978-3-642-78530-6_11
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-78532-0
Online ISBN: 978-3-642-78530-6
eBook Packages: Springer Book Archive